Back to Journals » Cancer Management and Research » Volume 16

Original Research

Efficacy and Safety of Re-Challenging PD-1 Inhibitors in Second-Line Treatment in Metastatic Nasopharyngeal Carcinoma Previously Treated with Chemotherapy and PD-1 Inhibitors

       

View citations on PubMed Central and Google Scholar